Health - /contrib/health/

Sorted by: Last Commented | Last Added Time
Experimental PrEP drug injected once every two months to begin global trial...
Submitted to Category: /contrib/hiv, /contrib/health/
Adherence challenges with pre-exposure prophylaxis (PrEP) could be overcome if experimental long-acting HIV drug is found to be effective and acceptable.
By AVERT on 2017-06-15 13:52 UTC
HIV drug resistance: a new threat for low- and middle-income countries...
Submitted to Category: /contrib/hiv, /contrib/health/
With 17 million people now accessing antiretroviral treatment worldwide, HIV drug resistance has the potential to unravel progress towards the Fast-Track target of ending AIDS by 2030.
By AVERT on 2017-06-15 13:51 UTC
Interventions to keep people in HIV care more cost-effective than a ‘treat all’ approach...
Submitted to Category: /contrib/hiv, /contrib/health/
Treatment scale-up has had major public health benefits. But where resources are scarce, interventions to keep people in care could be more cost-effective than moving to treat everybody living with HIV after diagnosis.
By AVERT on 2017-06-14 11:18 UTC
11 things to expect from an HIV home-test...
Submitted to Category: /contrib/hiv, /contrib/health/
HIV home-testing kits are available in a growing number of countries. They offer you the convenience of taking an HIV test in your own time and in the privacy of your own home – but are they for everyone?
By AVERT on 2017-06-14 11:15 UTC
People living with HIV have increased risk of neurocognitive impairment when they grow older...
Submitted to Category: /contrib/health/, /contrib/hiv
In the era of highly active antiretroviral treatment, HIV-associated neurocognitive disorders (HAND) still affect people living with HIV as they get older
By AVERT on 2017-06-14 11:08 UTC
Life expectancy for people with HIV is now near-normal – but only for those accessing treatment...
Submitted to Category: /contrib/hiv, /contrib/health/
There has been a vast decline in mortality among people with HIV who get on antiretroviral treatment – but who are we leaving behind?
By AVERT on 2017-06-13 14:35 UTC
Five things everyone should know about HIV...
Submitted to Category: /contrib/hiv, /contrib/health/
By AVERT on 2017-06-13 14:29 UTC
Treatment access masks wider barriers to 2020 targets...
Submitted to Category: /contrib/hiv, /contrib/health/
Treatment access gains are to be applauded – but we will get nowhere if we don’t prevent more new infections and reach out to key affected populations.
By AVERT on 2017-06-13 14:25 UTC
Holding our hands up for prevention...
Submitted to Category: /contrib/hiv, /contrib/health/
As we mark the 29th World AIDS Day, Sarah Hand says that with enough commitment, political will and funding we have the tools to achieve UNAIDS ambitious fast track targets but only if we recognise the need for a new approach to HIV prevention.
By AVERT on 2017-06-13 14:24 UTC
Ten pivotal moments in the HIV epidemic...
Submitted to Category: /contrib/hiv, /contrib/health/
This World AIDS Day we've chosen ten pivotal events from the history of the HIV epidemic you should know about.
By AVERT on 2017-06-13 14:23 UTC
Bats are global reservoir for deadly coronaviruses...
Submitted to Category: /contrib/science/, /contrib/health/
Finding could help researchers to better predict where these viruses are likely to make the jump from animals to people.
By aphrodite on 2017-06-13 03:20 UTC
Gates Foundation commits up to $300 million to global polio eradication effort...
Submitted to Category: /contrib/tech/, /contrib/health/
Microsoft founder and philanthropist Bill Gates announced Monday that the Bill and Melinda Gates Foundation has pledged up to $300 million towards a three-year effort to fully eradicate polio around the world. The announcement came at the Rotary Internati
By aphrodite on 2017-06-13 03:19 UTC
Hope for people living with multi-drug resistant HIV...
Submitted to Category: /contrib/hiv, /contrib/health/
Phase III trials of the intravenous drug ibalizumab have been found to significantly reduce viral load in people living with HIV who do not respond to existing treatment.
By AVERT on 2017-06-12 15:48 UTC
Treating fungal infections could prevent 1 million AIDS-related deaths by 2020...
Submitted to Category: /contrib/hiv, /contrib/health/
Over 300,000 AIDS-related deaths each year could be prevented through better diagnosis and treatment of fungal infections, according to new research from the Global Action Fund for Fungal Infections (GAFFI).
By AVERT on 2017-06-12 15:39 UTC
HIV testing kit that gives instant results to launch in UK...
Submitted to Category: /contrib/hiv, /contrib/health/
New HIV test gives people instant results, in the comfort of their own home, enabling more people to access HIV testing when and where it is convenient for them.
By AVERT on 2017-06-12 15:39 UTC
Capsule which delivers medicine for weeks after swallowing could revolutionise HIV treatment...
Submitted to Category: /contrib/hiv, /contrib/health/
A new pill technology has the potential to simplify HIV treatment and curb the rise of drug-resistant HIV.
By AVERT on 2017-06-12 15:35 UTC
13% of people living with HIV in the UK remain undiagnosed despite high standards of care...
Submitted to Category: /contrib/hiv, /contrib/health/
The UK has exceeded UNAIDS Fast-Track targets of getting people on treatment and virally suppressed, but falls behind on reaching those who are undiagnosed.
By AVERT on 2017-06-12 15:31 UTC
Discovery of chemical messages between viruses could provide new way to induce HIV latency...
Submitted to Category: /contrib/hiv, /contrib/health/
One of the first studies into viral communication shows that viruses that infect bacteria (phages) leave chemical messages for each other which help them decide whether to kill or linger. Disrupting these messages could provide a new way to control HIV.
By AVERT on 2017-06-12 15:22 UTC
“Knocking out” genes in cells of people living with HIV could lead to new methods of treatment, say scientists...
Submitted to Category: /contrib/hiv, /contrib/health/
Targeting the human genes that HIV takes over and uses to replicate could provide a new approach to HIV treatment and suppression although more research is required.
By AVERT on 2017-06-12 15:17 UTC
Strong trial results and high resistance barrier for integrase inhibitor treatment put Gilead on path to new HIV drug...
Submitted to Category: /contrib/hiv, /contrib/health/
Drug trial results for new integrase inhibitor show promising viral suppression rates.
By AVERT on 2017-06-12 15:15 UTC
  • Need an account?